Palisade Bio, Inc. Common Stock (PALI) stock analysis and AI prediction
The company facts of Palisade Bio, Inc. Common Stock, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Palisade Bio, Inc. Common Stock
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $204.6 million
- Size
- Micro cap
- Employees
- 14
- Headquarters
- CARLSBAD, CA
- Listed since
- April 28, 2021
- Website
- palisadebio.com
More Healthcare stocks
Other micro cap stocks
Keep going
PALI questions
What is the AI prediction for PALI stock?
Each market day our model rates Palisade Bio, Inc. Common Stock (PALI) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the PALI prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for PALI?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see PALI options?
The PALI options page opens its calls and puts, with price, volume, implied volatility and the Greeks.